Design of a phase III efficacy, immunogenicity, and safety study of 9-valent human papillomavirus vaccine in prevention of oral persistent infection in men

Posted on by

Contemporary Clinical Trials
Volume 115 April 2022
https://www.sciencedirect.com/journal/contemporary-clinical-trials/vol/115/suppl/C

 

Research article Abstract only
Design of a phase III efficacy, immunogenicity, and safety study of 9-valent human papillomavirus vaccine in prevention of oral persistent infection in men
Anna R. Giuliano, Timothy Wilkin, Oliver M. Bautista, Kyeongmi Cheon, … Yingmei Tu
Article 106592